Interactive Patient Engagement Solutions Market Analysis and Forecast to 2031: By Component (Software, Services), Delivery (On-Premise, Cloud), Therapy Area (CVD, Diabetes, Obesity, Fitness), and Region

Interactive Patient Engagement Solutions (IPES) are a type of healthcare technology that enables patients to actively participate in their own care. IPES typically involve some form of patient education, communication, and/or decision support tool that helps patients better understand their health condition, treatment options, and what to expect during their care journey. By engaging patients in their own care, IPES have the potential to improve health outcomes, reduce costs, and increase patient satisfaction.

Key Trends

There are a few key trends in interactive patient engagement solutions technology.

One is the trend toward more personalized medicine. This means that patients are being treated more as individuals, with tailored treatments based on their specific needs and genetic makeup.

Another trend is the move toward more patient-centered care. This means that patients are more involved in their own care, and are more likely to be involved in decision-making about their treatment.

Finally, there is a trend toward more use of technology to engage patients. This includes the use of mobile apps, online portals, and other tools to help patients manage their care and stay informed about their health.

Key Drivers

There are several key drivers of the Interactive Patient Engagement Solutions market. One of the most important drivers is the increasing focus on patient engagement and empowerment. This is being driven by the recognition that patients are more likely to be compliant with their treatment and follow their care plan if they are actively involved in their own care. Additionally, interactive patient engagement solutions can help to reduce the overall cost of care by improving communication between patients and providers and reducing the need for unnecessary tests and procedures.

Another key driver of the Interactive Patient Engagement Solutions market is the increasing use of mobile devices and the popularity of apps. Patients are increasingly using their smartphones and tablets to access their health information and manage their care. This trend is likely to continue as the capabilities of mobile devices continue to increase.

Finally, the Interactive Patient Engagement Solutions market is being driven by the increasing adoption of electronic health records (EHRs). EHRs provide a wealth of data that can be used to improve patient engagement. Additionally, EHRs can help to reduce the risk of errors and improve communication between patients and providers.

Restraints & Challenges

The key restraints and challenges in the interactive patient engagement solutions market are the lack of awareness among patients and the lack of standardization. There is a lack of awareness among patients about the benefits of using these solutions and the lack of standardization makes it difficult for providers to compare and select the right solution. In addition, the high cost of these solutions is a major challenge for the market growth.

Market Segments

The Interactive Patient Engagement Solutions Market is segmented by component, delivery, therapy area and region. By component the market is divided into software and services. Based on delivery it is segmented into on-premises and cloud. On the basis of therapy area it is bifurcated into CVD, diabetes, obesity and fitness. Region-wise the market is divided into North America, Europe, Asia-Pacific, and the Rest of the World.

Key Market Players

The Interactive Patient Engagement Solutions Market includes players such as IBM, McKesson Corporation, Allscripts, Cerner Corporation, Epic Systems Corporation, Orion Health, GetWellNetwork, Athenahealth, Oneview Healthcare and Meditech.

 

Why GIS?

Table of Contents

Chapter 1. Market Introduction
1.1. Objectives of the Study
1.2. Market Definition and Research & Scope
1.3. Research Methodologies
1.4. Market Estimation Techniques

Chapter 2. Executive Summary
2.1. Summary
2.2. Key Highlights of the Market

Chapter 3. Interactive Patient Engagement Solutions Market Outlook
3.1. Interactive Patient Engagement Solutions Market segmentation
3.2. Market Dynamics
3.2.1. Market Drivers
3.2.1.1. Driver 1
3.2.1.2. Driver 2
3.2.1.3. Driver 3
3.2.2. Market Restraints
3.2.2.1. Restraint 1
3.2.2.2. Restraint 2
3.2.3. Market Opportunities
3.2.3.1. Opportunity 1
3.2.3.2. Opportunity 2
3.3. Porter’s Five Forces Analysis
3.3.1. Threat of New Entrants
3.3.2. Threat of Substitutes
3.3.3. Bargaining Power of Buyers
3.3.4. Bargaining Power of Supplier
3.3.5. Competitive Rivalry
3.4. PESTLE Analysis
3.5. Value Chain Analysis
3.5.1. Raw Material Suppliers
3.5.2. Manufacturers
3.5.3. Wholesalers and/or Retailers
3.6. Impact of the Russia and Ukraine War on the Interactive Patient Engagement Solutions Market

Chapter 4. Economic Impact of COVID-19
4.1. Overall Impact of COVID-19
4.2. Impact of COVID On the Interactive Patient Engagement Solutions Market
4.3. Economic Impact Analysis

Chapter 5. Interactive Patient Engagement Solutions Market by Company
5.1. Market Overview
5.2. Software
5.2.1. Market Size and Forecast, 2021-2031 ($Million)
5.2.2. Market Size and Forecast, by Region, 2021-2031 ($Million)
5.3. Services
5.3.1. Market Size and Forecast, 2021-2031 ($Million)
5.3.2. Market Size and Forecast, by Region, 2021-2031 ($Million)

Chapter 6. Interactive Patient Engagement Solutions Market by Delivery Mode
6.1. Market Overview
6.2. On-Premise
6.2.1. Market Size and Forecast, 2021-2031 ($Million)
6.2.2. Market Size and Forecast, by Region, 2021-2031 ($Million)
6.3. Cloud
6.3.1. Market Size and Forecast, 2021-2031 ($Million)
6.3.2. Market Size and Forecast, by Region, 2021-2031 ($Million)

Chapter 7. Interactive Patient Engagement Solutions Market by Therapeutic Area
7.1. Market Overview
7.2. Cardiovascular diseases (CVD)
7.2.1. Market Size and Forecast, 2021-2031 ($Million)
7.2.2. Market Size and Forecast, by Region, 2021-2031 ($Million)
7.3. Diabetes
7.3.1. Market Size and Forecast, 2021-2031 ($Million)
7.3.2. Market Size and Forecast, by Region, 2021-2031 ($Million)
7.4. Obesity
7.4.1. Market Size and Forecast, 2021-2031 ($Million)
7.4.2. Market Size and Forecast, by Region, 2021-2031 ($Million)
7.5. Fitness
7.5.1. Market Size and Forecast, 2021-2031 ($Million)
7.5.2. Market Size and Forecast, by Region, 2021-2031 ($Million)

Chapter 8. Interactive Patient Engagement Solutions Market, by Region
8.1. Overview
8.2. North America
8.2.1. Key Market Trends and Opportunities
8.2.2. North America Interactive Patient Engagement Solutions Market Size and Forecast by Company, 2021-2031, ($Million)
8.2.3. North America Interactive Patient Engagement Solutions Market Size and Forecast by Delivery Mode, 2021-2031, ($Million)
8.2.4. North America Interactive Patient Engagement Solutions Market Size and Forecast by Therapeutic Area, 2021-2031, ($Million)
8.2.5. North America Interactive Patient Engagement Solutions Market Size and Forecast by Country, 2021-2031, ($Million)
8.2.6. The U.S.
8.2.6.1. The U.S. Interactive Patient Engagement Solutions Market Size and Forecast by Company, 2021-2031, ($Million)
8.2.6.2. The U.S. Interactive Patient Engagement Solutions Market Size and Forecast by Delivery Mode, 2021-2031, ($Million)
8.2.6.3. The U.S. Interactive Patient Engagement Solutions Market Size and Forecast by Therapeutic Area, 2021-2031, ($Million)
8.2.7. Canada
8.2.7.1. Canada Interactive Patient Engagement Solutions Market Size and Forecast by Company, 2021-2031, ($Million)
8.2.7.2. Canada Interactive Patient Engagement Solutions Market Size and Forecast by Delivery Mode, 2021-2031, ($Million)
8.2.7.3. Canada Interactive Patient Engagement Solutions Market Size and Forecast by Therapeutic Area, 2021-2031, ($Million)
8.2.8. Mexico
8.2.8.1. Mexico Interactive Patient Engagement Solutions Market Size and Forecast by Company, 2021-2031, ($Million)
8.2.8.2. Mexico Interactive Patient Engagement Solutions Market Size and Forecast by Delivery Mode, 2021-2031, ($Million)
8.2.8.3. Mexico Interactive Patient Engagement Solutions Market Size and Forecast by Therapeutic Area, 2021-2031, ($Million)
8.3. Europe
8.3.1. Key Market Trends and Opportunities
8.3.2. Europe Interactive Patient Engagement Solutions Market Size and Forecast by Company, 2021-2031, ($Million)
8.3.3. Europe Interactive Patient Engagement Solutions Market Size and Forecast by Delivery Mode, 2021-2031, ($Million)
8.3.4. Europe Interactive Patient Engagement Solutions Market Size and Forecast by Therapeutic Area, 2021-2031, ($Million)
8.3.5. Europe Interactive Patient Engagement Solutions Market Size and Forecast by Country, 2021-2031, ($Million)
8.3.6. Germany
8.3.6.1. Germany Interactive Patient Engagement Solutions Market Size and Forecast by Company, 2021-2031, ($Million)
8.3.6.2. Germany Interactive Patient Engagement Solutions Market Size and Forecast by Delivery Mode, 2021-2031, ($Million)
8.3.6.3. Germany Interactive Patient Engagement Solutions Market Size and Forecast by Therapeutic Area, 2021-2031, ($Million)
8.3.7. France
8.3.7.1. France Interactive Patient Engagement Solutions Market Size and Forecast by Company, 2021-2031, ($Million)
8.3.7.2. France Interactive Patient Engagement Solutions Market Size and Forecast by Delivery Mode, 2021-2031, ($Million)
8.3.7.3. France Interactive Patient Engagement Solutions Market Size and Forecast by Therapeutic Area, 2021-2031, ($Million)
8.3.8. U.K.
8.3.8.1. U.K. Interactive Patient Engagement Solutions Market Size and Forecast by Company, 2021-2031, ($Million)
8.3.8.2. U.K. Interactive Patient Engagement Solutions Market Size and Forecast by Delivery Mode, 2021-2031, ($Million)
8.3.8.3. U.K. Interactive Patient Engagement Solutions Market Size and Forecast by Therapeutic Area, 2021-2031, ($Million)
8.3.9. Spain
8.3.9.1. Spain Interactive Patient Engagement Solutions Market Size and Forecast by Company, 2021-2031, ($Million)
8.3.9.2. Spain Interactive Patient Engagement Solutions Market Size and Forecast by Delivery Mode, 2021-2031, ($Million)
8.3.9.3. Spain Interactive Patient Engagement Solutions Market Size and Forecast by Therapeutic Area, 2021-2031, ($Million)
8.3.10. Italy
8.3.10.1. Italy Interactive Patient Engagement Solutions Market Size and Forecast by Company, 2021-2031, ($Million)
8.3.10.2. Italy Interactive Patient Engagement Solutions Market Size and Forecast by Delivery Mode, 2021-2031, ($Million)
8.3.10.3. Italy Interactive Patient Engagement Solutions Market Size and Forecast by Therapeutic Area, 2021-2031, ($Million)
8.3.11. Rest of Europe
8.3.11.1. Rest of Europe Interactive Patient Engagement Solutions Market Size and Forecast by Company, 2021-2031, ($Million)
8.3.11.2. Rest of Europe Interactive Patient Engagement Solutions Market Size and Forecast by Delivery Mode, 2021-2031, ($Million)
8.3.11.3. Rest of Europe Interactive Patient Engagement Solutions Market Size and Forecast by Therapeutic Area, 2021-2031, ($Million)
8.4. Asia-Pacific
8.4.1. Key Market Trends and Opportunities
8.4.2. Asia-Pacific Interactive Patient Engagement Solutions Market Size and Forecast by Country, 2021-2031, ($Million)
8.4.3. Asia-Pacific Interactive Patient Engagement Solutions Market Size and Forecast by Delivery Mode, 2021-2031, ($Million)
8.4.4. Asia-Pacific Interactive Patient Engagement Solutions Market Size and Forecast by Company, 2021-2031, ($Million)
8.4.5. Asia-Pacific Interactive Patient Engagement Solutions Market Size and Forecast by Therapeutic Area, 2021-2031, ($Million)
8.4.6. China
8.4.6.1. China Interactive Patient Engagement Solutions Market Size and Forecast by Company, 2021-2031, ($Million)
8.4.6.2. China Interactive Patient Engagement Solutions Market Size and Forecast by Delivery Mode, 2021-2031, ($Million)
8.4.6.3. China Interactive Patient Engagement Solutions Market Size and Forecast by Therapeutic Area, 2021-2031, ($Million)
8.4.7. India
8.4.7.1. India Interactive Patient Engagement Solutions Market Size and Forecast by Company, 2021-2031, ($Million)
8.4.7.2. India Interactive Patient Engagement Solutions Market Size and Forecast by Delivery Mode, 2021-2031, ($Million)
8.4.7.3. India Interactive Patient Engagement Solutions Market Size and Forecast by Therapeutic Area, 2021-2031, ($Million)
8.4.8. Japan
8.4.8.1. Japan Interactive Patient Engagement Solutions Market Size and Forecast by Company, 2021-2031, ($Million)
8.4.8.2. Japan Interactive Patient Engagement Solutions Market Size and Forecast by Delivery Mode, 2021-2031, ($Million)
8.4.8.3. Japan Interactive Patient Engagement Solutions Market Size and Forecast by Therapeutic Area, 2021-2031, ($Million)
8.4.9. South Korea
8.4.9.1. South Korea Interactive Patient Engagement Solutions Market Size and Forecast by Company, 2021-2031, ($Million)
8.4.9.2. South Korea Interactive Patient Engagement Solutions Market Size and Forecast by Delivery Mode, 2021-2031, ($Million)
8.4.9.3. South Korea Interactive Patient Engagement Solutions Market Size and Forecast by Therapeutic Area, 2021-2031, ($Million)
8.4.10. Rest of APAC
8.4.10.1. Rest of APAC Interactive Patient Engagement Solutions Market Size and Forecast by Company, 2021-2031, ($Million)
8.4.10.2. Rest of APAC Interactive Patient Engagement Solutions Market Size and Forecast by Delivery Mode, 2021-2031, ($Million)
8.4.10.3. Rest of APAC Interactive Patient Engagement Solutions Market Size and Forecast by Therapeutic Area, 2021-2031, ($Million)
8.5. Rest of the World
8.5.1. Key Market Trends and Opportunities
8.5.2. Rest of the World Interactive Patient Engagement Solutions Market Size and Forecast by Company, 2021-2031, ($Million)
8.5.3. Rest of the World Interactive Patient Engagement Solutions Market Size and Forecast by Delivery Mode, 2021-2031, ($Million)
8.5.4. Rest of the World Interactive Patient Engagement Solutions Market Size and Forecast by Therapeutic Area, 2021-2031, ($Million)
8.5.5. Rest of the World Interactive Patient Engagement Solutions Market Size and Forecast by Country, 2021-2031, ($Million)
8.5.6. Latin America
8.5.6.1. Latin America Interactive Patient Engagement Solutions Market Size and Forecast by Company, 2021-2031, ($Million)
8.5.6.2. Latin America Interactive Patient Engagement Solutions Market Size and Forecast by Delivery Mode, 2021-2031, ($Million)
8.5.6.3. Latin America Interactive Patient Engagement Solutions Market Size and Forecast by Therapeutic Area, 2021-2031, ($Million)
8.5.7. Middle East
8.5.7.1. Middle East Interactive Patient Engagement Solutions Market Size and Forecast by Company, 2021-2031, ($Million)
8.5.7.2. Middle East Interactive Patient Engagement Solutions Market Size and Forecast by Delivery Mode, 2021-2031, ($Million)
8.5.7.3. Middle East Interactive Patient Engagement Solutions Market Size and Forecast by Therapeutic Area, 2021-2031, ($Million)
8.5.8. Africa
8.5.8.1. Africa Interactive Patient Engagement Solutions Market Size and Forecast by Company, 2021-2031, ($Million)
8.5.8.2. Africa Interactive Patient Engagement Solutions Market Size and Forecast by Delivery Mode, 2021-2031, ($Million)
8.5.8.3. Africa Interactive Patient Engagement Solutions Market Size and Forecast by Therapeutic Area, 2021-2031, ($Million)

Chapter 9. Competitive Landscape
9.1. Market Overview
9.2. Market Share Analysis/Key Player Positioning
9.3. Developmental Strategy Benchmarking
9.3.1. New Product Development
9.3.2. Product Launches
9.3.3. Business Expansions
9.3.4. Partnerships, Joint Ventures, and Collaborations
9.3.5. Mergers and Acquisitions

Chapter 10. Company Profiles
10.1. IBM
10.1.1. Company Snapshot
10.1.2. Financial Performance
10.1.3. Product Offerings
10.1.4. Key Strategic Initiatives
10.1.5. SWOT Analysis
10.2. McKesson Corporation
10.2.1. Company Snapshot
10.2.2. Financial Performance
10.2.3. Product offerings
10.2.4. Key Strategic Initiatives
10.2.5. SWOT Analysis
10.3. Allscripts
10.3.1. Company Snapshot
10.3.2. Financial Performance
10.3.3. Product offerings
10.3.4. Key Strategic Initiatives
10.3.5. SWOT Analysis
10.4. Cerner Corporation
10.4.1. Company Snapshot
10.4.2. Financial Performance
10.4.3. Product offerings
10.4.4. Key Strategic Initiatives
10.4.5. SWOT Analysis
10.5. Epic Systems Corporation
10.5.1. Company Snapshot
10.5.2. Financial Performance
10.5.3. Product offerings
10.5.4. Key Strategic Initiatives
10.5.5. SWOT Analysis
10.6. Orion Health
10.6.1. Company Snapshot
10.6.2. Financial Performance
10.6.3. Product offerings
10.6.4. Key Strategic Initiatives
10.6.5. SWOT Analysis
10.7. GetWellNetwork
10.7.1. Company Snapshot
10.7.2. Financial Performance
10.7.3. Product offerings
10.7.4. Key Strategic Initiatives
10.7.5. SWOT Analysis
10.8. Athenahealth
10.8.1. Company Snapshot
10.8.2. Financial Performance
10.8.3. Product offerings
10.8.4. Key Strategic Initiatives
10.8.5. SWOT Analysis
10.9. Oneview Healthcare
10.9.1. Company Snapshot
10.9.2. Financial Performance
10.9.3. Product offerings
10.9.4. Key Strategic Initiatives
10.9.5. SWOT Analysis
10.10. Meditech
10.10.1. Company Snapshot
10.10.2. Financial Performance
10.10.3. Product offerings
10.10.4. Key Strategic Initiatives
10.10.5. SWOT Analysis

*The list of company is subject to change during the final compilation of the report

 

 

Key Players
  • IBM
  • McKesson Corporation
  • Allscripts
  • Cerner Corporation
  • Epic Systems Corporation
  • Orion Health
  • GetWellNetwork
  • Athenahealth
  • Oneview Healthcare
  • Meditech
Market Segments

 By component

  • Software
  • Services

By Delivery Mode

  • On-Premise
  • Cloud

By Therapeutic area

  • Cardiovascular diseases (CVD)
  • Diabetes
  • Obesity
  • Fitness

By Region

  • North America
    • The U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • China
    • India
    • Japan
    • South Korea
    • Rest of Asia-Pacific
  • Rest of the World
    • Latin America
    • Middle East
    • Africa

Order this Report

Have questions about the scope of the report ?

Have specific requirements ?

Budget Constraints ?

Related Reports

Intubation tubes, also referred to as endotracheal tubes,…
Tumor ablation is a minimally invasive procedure that…
The global immune-oncology assay market was valued at…
The global Organ Care Products Market was valued…
Bioresorbable Vascular Scaffold (BVS) is an innovative medical…
The dental equipment market was valued at over…
Small Molecule Injectable is a type of drug…
The global stoma/ostomy care market was valued at…
The global immunoassay market was valued at USD…
Hyaluronic acid-based dermal fillers are a type of…